Sat.Oct 08, 2022 - Fri.Oct 14, 2022

article thumbnail

Closing the Historic Routine-Vaccination Gap

Drug Topics

Pharmacists can play a key role in helping to improve backsliding vaccination rates.

Vaccines 591
article thumbnail

The digital therapeutics revolution is happening and Big Pharma is buying in — with caution

PharmaVoice

Companies like Pfizer, Novartis, Sanofi and BMS are diving into the world of digital therapeutics while recognizing the limitations of the young field.

290
290
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five Achievements You Need To Unlock To Become An Antibiotic Ninja

IDStewardship

In this article a pharmacist with specialized training in infectious diseases discusses five key areas of study to master in the field of antimicrobial pharmacotherapy, to become an antibiotic ninja. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 11 October 2022. It is commonplace for learners such as students and residents to struggle with infectious diseases pharmacotherapy.

263
263
article thumbnail

Pharmacists Can Affirm Transgender, Non-Binary Patients

Pharmacy Times

A presentation at the AMCP Nexus conference focuses on the health care disparities and pharmacotherapy options for gender affirmation.

181
181
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Live Now: Drug Topics® Annual Salary Survey

Drug Topics

Readers, we want to hear from you.

586
586
article thumbnail

Woman of the Week: HBA’s Nikki Jones

PharmaVoice

As the Healthcare Businesswomen’s Association’s first chief people and DEI officer, Jones is poised to tackle pay gap inequity, systemic gender bias and leadership barriers impeding women of color.

264
264

More Trending

article thumbnail

Clinical Results Support Greater Use of Oncology Biosimilars

Pharmacy Times

Presenters at the AMCP Nexus conference explore outcomes data and whether these medications should be substituted for reference products more frequently.

161
161
article thumbnail

Industry Trends: What to Watch For

Drug Topics

From biosimilars to artificial intelligence, these are the trends poised to take community pharmacy by storm.

article thumbnail

New partnership may give MDMA an edge in the psychedelics space

PharmaVoice

While LSD and psilocybin steal the spotlight, drug developers are also exploring MDMA for a wide swath of neurological illnesses.

262
262
article thumbnail

Human neurons implanted in a rodent’s brain lead a rat to water — and make it drink

STAT

The scientist flicked on a laser, filling the rat’s brain with blue light. The rodent, true to its past two weeks of training, scampered across its glass box to a tiny spout, where it was duly rewarded with a drink of water. From the outside, this would appear to be a pretty run-of-the-mill neuroscience experiment, except for the fact that the neurons directing the rat to its thirst-quenching reward didn’t contain any rat DNA.

141
141
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Specialty Drugs Account for Nearly Half of Pharmacy Drug Spend in 2021

Pharmacy Times

Keynote speaker at the AMCP Nexus conference discusses recent FDA approvals and those scheduled over the next year.

FDA 154
article thumbnail

Spotlight on Mental Health: World Mental Health Day 2022

Drug Topics

Make mental health a priority.

532
532
article thumbnail

What’s your leadership brand?

PharmaVoice

Pharma industry leaders share their brand personas.

246
246
article thumbnail

Robotic capsule could replace injected biologics

European Pharmaceutical Review

Scientists at MIT have demonstrated that a novel robotic capsule could potentially replace conventional biologic injection methods by tunnelling through the intestinal mucus barrier to deliver insulin. The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide.

137
137
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Pharmacists Can Help Identify, Treat Anemia of CKD

Pharmacy Times

Panelists at the AMCP Nexus conference discuss the burden of undertreated and untreated chronic kidney disease.

149
149
article thumbnail

PTSD Therapies on the Fast Track

Drug Topics

Several drugs with novel mechanisms of action have been put on the pathway for speedier approval decisions by the FDA. Phase 2 and 3 trials are underway.

FDA 529
article thumbnail

Robotic pills could open a world of possibilities for the biologics market

PharmaVoice

As the oral biologic market heats up, Rani Therapeutics is looking to dominate the field with its robotic pill for treatment of chronic conditions.

246
246
article thumbnail

2022 CVS Health Minority Scholarship For Pharmacy Students Winners Announced

Pharmacy Is Right For Me

We’re thrilled to announce the winners of the 2022 CVS Health Minority Scholarship for Pharmacy Students! The CVS Health Minority Scholarship for Pharmacy Students is a scholarship program launched in 2019 thanks to the generosity of CVS Health in partnership with the American Association of Colleges of Pharmacy (AACP). About this scholarship program The scholarship program is designed to support and promote a diverse population of student pharmacists by reducing financial barriers for underrepr

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Unmet Needs in Management of C. Difficile Infection (CDI)

Pharmacy Times

Bincy Abraham, MD, MS; Thomas Lodise, PharmD, PhD; Teena Chopra, MD, MPH; and Paul Feuerstadt, MD, share unmet needs, including access to therapies, in treatment of C. difficile infection (CDI).

149
149
article thumbnail

Mental, Behavioral Health Issues Call for Creative Solutions

Drug Topics

In an ideal world, pharmacists would be able to spot patients in mental health crisis and provide appropriate solutions.

504
504
article thumbnail

Where the CEO of ADC Therapeutics sees ‘huge potential’ in the tech beyond oncology

PharmaVoice

The “magic bullet” approach of ADCs has been a breakthrough in cancer care — but this excitement could be just the beginning.

246
246
article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division Janssen – has been set up to tackle the environmental impact of digital health products, specifically aimed at minimising waste that could end up in landfill. The Digital Health in a Circular Economy (DiCE) group was formed earlier this year with the aim of developing ways to “design, collect, directly reuse, refurbish, remanufacture, and recycle digital health devices.” The programme

Labelling 124
article thumbnail

Women Pharmacist Day Celebrates Trailblazers in the Field

Pharmacy Times

Suzanne Soliman, PharmD, BCMAS, discusses how she will be celebrating the important contributions of women pharmacists.

149
149
article thumbnail

October 2022: In This Issue

Drug Topics

A look at what’s to come in the October issue of Drug Topics®.

504
504
article thumbnail

Citius Pharmaceuticals sees golden opportunities in late-stage specialty assets

PharmaVoice

CEO Leonard Mazur explains how the company’s hoping to unlock the potential of its varied pipeline.

246
246
article thumbnail

RemeGen receives ODD for myasthenia gravis treatment

European Pharmaceutical Review

RemeGen has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for its proprietary novel fusion protein Telitacicept (RC18) for the treatment of myasthenia gravis (MG). Telitacicept is a proprietary novel fusion protein from RemeGen to treat autoimmune diseases. It is constructed with the extracellular domain of the human transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) receptor and the fragment crystallisable

article thumbnail

Mentoring, Supporting Others Can Help Advance Women Pharmacists

Pharmacy Times

Nakia Eldridge, PharmD, MBA, discussed her career, the impacts of COVID-19 on women in pharmacy, and how mentorship can pave the way for more women pharmacists.

149
149
article thumbnail

What CBD Brings to the Table for Dermatologic Concerns

Drug Topics

Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda professional to discuss what CBD is used for in dermatology.

502
502
article thumbnail

Patient insights data

PharmaVoice

While there are many sources of real-world evidence, there’s growing interest and focus on capturing patient generated insights to capture a more specific level of understanding for a given therapy.

246
246
article thumbnail

Faster brain imaging technique seems to overcome limitations of current MRI scans

STAT

Research often proceeds in a logical progression, new studies building upon a detailed understanding of the underlying processes revealed by earlier work. But a new brain imaging technique that can directly track the activity of neurons emerged from one of academics’ favorite questions: “What would happen if we tried doing it this way?

123
123
article thumbnail

How Cancer Vaccines Can Educate an Immune Response in Advanced Cancer Patients

Pharmacy Times

Jeremy Graff, chief scientific officer at IMV, discusses why the development of viable cancer vaccines is a bit more slow-going in comparison to the fast-paced development of COVID-19 vaccines during the pandemic.

Vaccines 144
article thumbnail

Follow the Money

Drug Topics

As he prepared to move house, our columnist was struck by the similarities between a yard sale and the prescription drug pricing infrastructure.

502
502
article thumbnail

Coming out of stealth, RIGImmune aims to catch up with ever-mutating viruses

PharmaVoice

President Susan Sobolov discusses how the startup is building on the work of two powerhouse Yale scientists to advance candidates for viruses — and beyond.

246
246